Atea Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Atea Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $8.67. The average 1-year stock price forecast is 98.85% higher than the current stock price, while the lowest is $6.00 (+37.61%) and the highest is $10 (+129.36%).

Price Target: $8.67 (+98.85%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$6.00	$8.67	$10	$10
Change	+37.61%	+98.85%	+129.36%	+129.36%

* Price targets were last updated on May 18, 2026.

Analyst Ratings

The average analyst rating for Atea Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Nov '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	1	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Maxwell Skor Morgan Stanley	Morgan Stanley	Hold Maintains $6	Hold	Maintains	$6	+37.61%	May 18, 2026
Andy Hsieh William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	May 13, 2026
Umer Raffat Evercore ISI	Evercore ISI	Buy Maintains $6 → $10	Buy	Maintains	$6 → $10	+129.36%	Mar 9, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

30.17M

EPS This Year

-1.93

from -1.94

EPS Next Year

-1.39

from -1.93

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	351.37M	-	-	-	-	-
Gross Profit	184.16M	-62.39M	-70.61M	-83.37M	-146.53M	-
Gross Margin	52.41%	-	-	-	-	90.00%
Operating Income	138.38M	-111.10M	-120.53M	-132.22M	-179.40M	-163.97M
Net Income	121.19M	-115.91M	-135.96M	-168.39M	-158.35M	-168.00M
EPS	-	-	-	-	-1.94	-1.93
Free Cash Flow	-127.65M	-69.52M	-9.76M	-39.55M	-71.38M	-107.00M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.93
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-